Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1853.92% is 73% above its 5-year average of -6761.13%, near the high end of its 5-year range (-24416.32%–-50.37%).
19.94% below its 12-month average of -1545.67%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1300.30%.
OPERATING MARGIN
-1853.92%
OPERATING MARGIN AVG TTM
-1545.67%
OPERATING MARGIN AVG 3Y
-3128.97%
OPERATING MARGIN AVG 5Y
-6761.13%
OPERATING MARGIN AVG 10Y
-4212.45%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-19.94%
CURRENT VS 3Y AVG
+40.75%
CURRENT VS 5Y AVG
+72.58%
CURRENT VS 10Y AVG
+55.99%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Cibus, Inc.
Market Cap
$128.24M
Operating Margin
-1853.92%
TTM Avg
-1545.67%
3Y Avg
-3128.97%
5Y Avg
-6761.13%
Market Cap
$129.14M
Operating Margin
-27450.00%
TTM Avg
-16372.79%
3Y Avg
-10624.45%
5Y Avg
-7949.52%
Market Cap
$130.05M
Operating Margin
-11.60%
TTM Avg
-17.18%
3Y Avg
-31.98%
5Y Avg
-39.70%
Market Cap
$125.27M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$134.74M
Operating Margin
-7.85%
TTM Avg
-2.10%
3Y Avg
-0.51%
5Y Avg
4.29%
Market Cap
$119.09M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$118.63M
Operating Margin
-33.18%
TTM Avg
-17.71%
3Y Avg
-9.45%
5Y Avg
-4.00%
Market Cap
$118.50M
Operating Margin
-754.08%
TTM Avg
-1999.61%
3Y Avg
-1887.55%
5Y Avg
-2072.97%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cibus, Inc. (CBUS) | $128.24M | -1853.92% | -1545.67% | -3128.97% | -6761.13% |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | -27450.00% | -16372.79% | -10624.45% | -7949.52% |
| Health Catalyst, Inc. (HCAT)vs › | $130.05M | -11.60% | -17.18% | -31.98% | -39.70% |
| enGene Holdings Inc. (ENGN)vs › | $125.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | -7.85% | -2.10% | -0.51% | 4.29% |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $119.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| BGM Group Ltd. (BGM)vs › | $118.63M | -33.18% | -17.71% | -9.45% | -4.00% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $118.50M | -754.08% | -1999.61% | -1887.55% | -2072.97% |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | -1220.49% | -1443.83% | -998.11% | -830.42% |
Gross Margin
-62.8%
Operating Margin
-1853.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1300.30% |
| 2026-03-31 | -721.00% |
| 2025-12-31 | -1273.32% |
| 2025-09-30 | -2510.24% |
| 2025-06-30 | -1923.47% |
| 2025-03-31 | -4020.41% |
| 2024-12-31 | -1487.13% |
| 2024-09-30 | -13851.90% |
| 2024-06-30 | -2563.48% |
| 2024-03-31 | -3385.87% |
| 2023-12-31 | -24416.32% |
| 2023-09-30 | -5430.95% |
| 2023-06-30 | -9802.54% |
| 2023-03-31 | -10626.19% |
| 2022-12-31 | -7888.10% |
| 2022-09-30 | -14769.05% |
| 2022-06-30 | -16500.00% |
| 2022-03-31 | -19028.13% |
| 2021-12-31 | -345.34% |
| 2021-09-30 | -89.63% |
| 2021-06-30 | -50.37% |
| 2021-03-31 | -219.92% |
| 2020-12-31 | -93.26% |
| 2020-09-30 | -172.68% |
| 2020-06-30 | -478.89% |
| 2020-03-31 | -448.30% |
| 2019-12-31 | -316.40% |
| 2019-09-30 | -360.40% |
| 2019-06-30 | -2326.47% |
| 2019-03-31 | -4791.72% |
| 2018-12-31 | -431400.00% |
| 2018-09-30 | -28514.81% |
| 2018-06-30 | -3822.45% |
| 2018-03-31 | -39054.55% |
| 2017-12-31 | -3662.90% |
| 2017-09-30 | -29425.00% |
| 2017-06-30 | -1452.91% |
| 2017-03-31 | -5070.91% |
| 2016-12-31 | -6348.61% |
| 2016-09-30 | -2366.67% |
| 2016-06-30 | -2148.28% |
| 2016-03-31 | -2416.04% |
